(Q37732614)

22 August 2017

1 reference

title

The changing demographic pattern of multiple sclerosis epidemiology (English)

1 reference

22 August 2017

0 references

0 references

1 reference

1

Nils Koch-Henriksen

0 references

Per Soelberg Sørensen

series ordinal

2

object named as

Per Soelberg Sørensen

1 reference

22 August 2017

Nils Koch-Henriksen

1

1 reference

22 August 2017

publication date

1 May 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

9

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

520-532

1 reference

Medical facilities and the prevalence of multiple sclerosis

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Epidemiologic evidence for multiple sclerosis as an infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Histocompatibility determinants in multiple sclerosis, with special reference to clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Genetics of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Epistasis: multiple sclerosis and the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

A population-based study of multiple sclerosis in twins

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The British Isles survey of multiple sclerosis in twins

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Concordance for multiple sclerosis in Danish twins: an update of a nationwide study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Environmental factors and multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Twin study of multiple sclerosis: An epidemiologic inquiry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Serological differences in monozygotic twin pairs discordant for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in the faroe islands: I. Clinical and epidemiological features

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in the Faroe Islands. II. Clinical update, transmission, and the nature of MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Analysis of the 'epidemic' of multiple sclerosis in the Faroe Islands. I. Clinical and epidemiological aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The accuracy of prevalence rates of multiple sclerosis: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Epidemiology of multiple sclerosis. Does this really point toward an etiology? Lectio Doctoralis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in north-east Scotland.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in the Orkney and Shetland Islands. I: Epidemiology, clinical factors, and methodology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

A further prevalence study of multiple sclerosis in north-east Scotland

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in northern Italy. Prevalence in the province of Ferrara in 1978

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Italy: a medium- or high-risk area for multiple sclerosis? An epidemiologic study in Barbagia, Sardinia, southern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in Iceland: 1. Evidence of a postwar epidemic.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The frequency of multiple sclerosis in Mediterranean Europe. An incidence and prevalence study in Barbagia, Sardinia, insular Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in Finland: evidence of increasing frequency and uneven geographic distribution.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Western Norway, a high-risk area for multiple sclerosis: a prevalence/incidence study in the county of Hordaland.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Epidemiological investigations into multiple sclerosis in Southern Hesse I

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Declining incidence of multiple sclerosis in the Orkney Islands

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The frequency of multiple sclerosis in Italy: a descriptive study in Ferrara

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in a south London borough.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Sardinia, a high-risk area for multiple sclerosis: a prevalence and incidence study in the district of Alghero.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in the Shetland Islands: an update.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Epidemiology of multiple sclerosis: incidence and prevalence rates in Denmark 1948-64 based on the Danish Multiple Sclerosis Registry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Incidence of multiple sclerosis: a periodic or stable phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

A prevalence study of multiple sclerosis in L'Aquila, central Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The prevalence of multiple sclerosis in south east Wales

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The incidence and mortality of multiple sclerosis in south east Wales

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Increasing incidence of multiple sclerosis in South Lower Saxony, Germany

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in Spain: an epidemiological study of the Alcoy health region, Valencia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Epidemiologic trends in multiple sclerosis in Møre and Romsdal, Norway: a prevalence/incidence study in a stable population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The prevalence of multiple sclerosis in the Southampton and South West Hampshire Health Authority

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Frequency of multiple sclerosis in Valle d'Aosta, 1971-1985.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in the Cambridge health district of east Anglia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

High prevalence of multiple sclerosis in Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in Iceland, with observations on the alleged epidemic in the Faroe Islands

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in Flanders, Belgium

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in the region of Osona, Catalonia, northern Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Epidemiological survey of multiple sclerosis in the provinces of Reggio Emilia and Modena, Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

A prevalence survey of multiple sclerosis in Sussex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in the north Cambridgeshire districts of East Anglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in island populations: prevalence in the Bailiwicks of Guernsey and Jersey

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Epidemiology of multiple sclerosis in the county of Vestfold, eastern Norway: incidence and prevalence calculations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in Italy. A reappraisal of incidence and prevalence in Ferrara.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in south Cambridgeshire: incidence and prevalence based on a district register

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Epidemiology of multiple sclerosis in Northwestern Sardinia: further evidence for higher frequency in Sardinians compared to other Italians

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in Rochdale

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in the province of Teruel, Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in Móstoles, central Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

An epidemiological study of multiple sclerosis in central Sardinia, Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The prevalence of multiple sclerosis in the Leeds Health Authority

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

An epidemiologic study of multiple sclerosis in Northern Ireland.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in the sanitary district of Calatayud, Northern Spain: is Spain a zone of high risk for this disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The prevalence of multiple sclerosis in Tayside, Scotland: do latitudinal gradients really exist?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in Valladolid, northern Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in North Norway, and first appearance in an indigenous population.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Incidence of multiple sclerosis in Bagheria City, Sicily, Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in the L'Aquila district, central Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Frequency of Multiple Sclerosis in Menorca, Balearic Islands, Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

High incidence and increasing prevalence of MS in Enna (Sicily), southern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence and incidence of multiple sclerosis in Catania, Sicily.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Increasing prevalence of multiple sclerosis in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in Västerbotten County in northern Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of Multiple Sclerosis in Austria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in Malta in 1999: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Epidemiology of multiple sclerosis in the Canary Islands (Spain): a study on the island of La Palma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Trends in prevalence and incidence of multiple sclerosis in Bajo Aragón, Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Increasing frequency of multiple sclerosis in Padova, Italy: a 30 year epidemiological survey.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Incidence (1988-97) and prevalence (1997) of multiple sclerosis in Västerbotten County in northern Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence and incidence of multiple sclerosis in Las Palmas, Canary Islands, Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in Nord-Trøndelag County, Norway: a prevalence and incidence study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in southern Europe: Monreale City, Italy. A twenty-year follow-up incidence and prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Possible increasing risk of multiple sclerosis in Catania, Sicily

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

A possible spatial and temporal cluster of multiple sclerosis in the town of Linguaglossa, Sicily.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The prevalence of multiple sclerosis in the north-west Italian province of Genoa.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Bayesian mapping of multiple sclerosis prevalence in the province of Pavia, northern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The prevalence of multiple sclerosis in the District of Santarém, Portugal.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in Santiago de Compostela (Galicia, Spain)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in the province of Ferrara : evidence for an increasing trend

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

High prevalence and fast rising incidence of multiple sclerosis in Caltanissetta, Sicily, southern Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in the Republic of San Marino: a prevalence and incidence study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

High prevalence of multiple sclerosis in the Swedish county of Värmland

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Increasing prevalence and incidence of multiple sclerosis in South East Wales

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Epidemiology of multiple sclerosis in Glasgow

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis prevalence among Sardinians: further evidence against the latitude gradient theory

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Higher than expected prevalence of multiple sclerosis in northern Colorado: dependence on methodologic issues

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The incidence and prevalence of multiple sclerosis in Newfoundland and Labrador, 1960-1984.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Epidemiology of multiple sclerosis in London and Middlesex County, Ontario, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in Key West, Florida.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence, incidence, and characteristics of multiple sclerosis in Westlock County, Alberta, Canada.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Epidemiology of multiple sclerosis in western Poland--a comparison between prevalence rates in 1965 and 1981

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of MS in south Estonia. Evidence of a new border of the Fennoscandian focus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in Bulgaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The prevalence of multiple sclerosis, distribution of clinical forms of the disease and functional status of patients in Csongrád County, Hungary

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in Belgrade, Yugoslavia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Epidemiological data of multiple sclerosis in the province of Evros, Greece.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis door-to-door survey in Maltepe, Istanbul, Turkey.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Epidemiology of multiple sclerosis in western Herzegovina

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence and incidence of multiple sclerosis in western Greece: a 23-year survey.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The prevalence of multiple sclerosis in the Hungarian city of Szeged.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Ethnic and HLA patterns related to multiple sclerosis in Wellington, New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Occurrence of multiple sclerosis in the north and south of New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence survey of multiple sclerosis in the Australian Capital Territory

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis is more prevalent in northern New Zealand than previously reported.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis amongst Chinese in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis amongst Chinese in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in Asahikawa, a city in northern Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

A population-based survey of multiple sclerosis in Shanghai, China

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Increasing prevalence and incidence of multiple sclerosis in northern Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The clinical course of multiple sclerosis patients in Hong Kong.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in the Parsis of Bombay

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of Multiple Sclerosis: A Door-To-Door Survey in Lan Cang La Hu Zu Autonomous County, Yunnan Province of China

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence and pattern of multiple sclerosis in Benghazi, north-eastern Libya

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in Kuwait: clinical and epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Epidemiology of multiple sclerosis in Kuwait: new trends in incidence and prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in Jordan: a clinical and epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in Isfahan, Iran.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in KwaZulu Natal, South Africa: an epidemiological and clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in Isfahan, Iran.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of Multiple Sclerosis in the City of São Paulo, Brazil, in 1990

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

MS and neuromyelitis optica in Martinique (French West Indies)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The prevalence of multiple sclerosis in the city of São Paulo, Brazil, 1997

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Argentine Patagonia: prevalence and clinical features of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in Buenos Aires, Argentina using the capture-recapture method

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in Bogotá, Colombia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in southern Europe. A prevalence study in the sociosanitary district of Copparo, northern Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Increased incidence and prevalence of multiple sclerosis in Los Alamos County, New Mexico.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Epidemiology of multiple sclerosis in the north-east (Grampian region) of Scotland--an update

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in Lanzarote (Canary Islands)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple Sclerosis in Galion, Ohio: Prevalence and Results of a Case-Control Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Prevalence of multiple sclerosis in five rural Suffolk practices

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The prevalence of multiple sclerosis in the Sanitary District of Vélez-Málaga, southern Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in Fife.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Regional variation of multiple sclerosis prevalence in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Incidence of multiple sclerosis in Macomer, Sardinia, 1912-1981: onset of the disease after 1950.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Incidence of multiple sclerosis in Denmark 1948-1982: a descriptive nationwide study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Incidence of multiple sclerosis in Møre and Romsdal, Norway from 1950 to 1991. An age-period-cohort analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Multiple sclerosis in Tayside, Scotland: detection of clusters using a spatial scan statistic.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Increasing incidence of multiple sclerosis in the province of Sassari, northern Sardinia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Incidence of multiple sclerosis in the urban area of Erfurt, Thuringia, Germany

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Geographic distribution of MS in New Zealand: evidence from hospital admissions and deaths

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Evidence for lower susceptibility to multiple sclerosis in Japanese-Americans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The relation of ultraviolet radiation and multiple sclerosis in Newfoundland.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Regional variations in the prevalence of multiple sclerosis in French farmers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Geographic and climatic factors and multiple sclerosis in some districts of Bulgaria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Vitamin D as an immune modulator in multiple sclerosis, a review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Vitamin D: a candidate for the environmental effect in multiple sclerosis - observations from Norway

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

The protective role of Langerhans’ cells and sunlight in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Sex ratio of multiple sclerosis in Canada: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Retrospective comparison of the original and revised McDonald criteria in a general neurology practice in Ireland

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Parent-of-origin effects in MS: observations from avuncular pairs.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Parent-of-origin effect in multiple sclerosis: observations in half-siblings

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970064-8

7 January 2021

10.1016/S1474-4422(10)70064-8

Identifiers

DOI

1 reference

22 August 2017

1 reference